Purchase of Shares by Employee Benefit Trust
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your ELIX notes
Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, announces that the Elixirr International plc Employee Benefit Trust (the "EBT") purchased from certain Directors, PDMRs, employees and shareholders of the Company (the "Purchase") 1,419,890 ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 565 pence per Ordinary Share.
The Purchase has been made at the instruction of Apex Group Fiduciary Services Limited as independent trustee of the EBT following a recommendation by the Board of the Company. The decision to make the Purchase is to ensure that the EBT has sufficient shares to satisfy demand including for satisfaction of options, equity for new Partners and equity for those joining the firm through acquisition. Accordingly, the Purchase will mitigate the need for dilution in the equity of the Company as it executes on its growth strategy.
Following the Purchase, the EBT's beneficial holding is 1,782,344 Ordinary Shares representing 3.8 per cent of the issued share capital of the Company.
Participation by certain Directors and PDMRs in the Purchase are outlined in the table below:
| Director/PDMR | P osition | Ordinary Shares Sold | Share Sale Price | Resultant Holding | % of total voting rights |
|---|---|---|---|---|---|
| Gavin Patterson | Chair | 176,991 | 565p | 439,679 | 0.9% |
| Simon Retter | Non-Executive Director | 88,496 | 565p | 288,237 | 0.6% |
| Ian Ferguson | Executive Director | 176,991 | 565p | 2,417,091 | 5.1% |
| Nicholas Willott | Finance Director & Company Secretary | 20,000 | 565p | 254,073 | 0.5% |
| Clare Filby | Chief Operating Officer | 35,398 | 565p | 498,400 | 1.1% |
| Eric Rich | Partner | 79,651 | 565p | 592,118 | 1.3% |
| Brandon Bichler | Partner | 69,479 | 565p | 642,712 | 1.4% |
| Dieter Halfar | Partner | 44,248 | 565p | 316,461 | 0.7% |
| Daniel Garsin | Partner | 24,651 | 565p | 221,855 | 0.5% |
| 2. | Reason for the Notification | ||||
| a) | Position/status | 1. Director 2. Director 3. Director 4. PDMR 5. PDMR 6. PDMR 7. PDMR 8. PDMR 9. PDMR | |||
| b) | Initial notification/Amendment | Initial Notification | |||
| a) | Name | Elixirr International plc | |||
| b) | LEI | 213800MKY7OHMVAKW681 | |||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.005p each ("Ordinary Shares") | |||
| Identification code | GB00BLPHTX84 | ||||
| b) | Nature of the transaction | Sale of Ordinary Shares | |||
| c) | Price(s) and volume(s) | Director/PDMR Price(s) Volume(s) Gavin Patterson 565p 176,991 Simon Retter 565p 88,496 Ian Ferguson 565p 176,991 Nicholas Willott 565p 20,000 Clare Filby 565p 35,398 Eric Rich 565p 79,651 Brandon Bichler 565p 69,479 Dieter Halfar 565p 44,248 Daniel Garsin 565p 24,651 | |||
| d) | Aggregated information: · Aggregated volume · Price | As in 4c) above | |||
| e) | Date of the transaction | 8 July 2024 | |||
| f) | Place of the transaction | Off market transaction |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.